agree with the competition comment - you may remember when I met with the clinical trial pharmacist (regarding Novogen at the time probably close to a year ago and I relayed the conversation here in regards to trials and takeovers) most often Pharmas buy out companies that compete with other drugs even the ones that hold the main drug of a cure so that no one else can take market share away